GlassScriptPhysician profile
James Alver
NPI 1356337240
$59,495.27
in general payments reported to CMS, 2019-2025
33 companies · $679 in 2025
The $679 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,939 · 2020: $5,817 · 2021: $701 · 2022: $358 · 2023: $657 · 2024: $44K · 2025: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $44K · Food and Beverage: $2,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $43,611.33 |
| Food and Beverage | $2,069.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $43,668.33 | 2023-2024 | Single Use Biopsy Valve (Sterile), Single Use Electrosurgical Snare Sd-400, Single Use Electrosurgical Hemostatic Forceps |
| Astellas Pharma US INC | $12,243.55 | 2019-2023 | Xtandi |
| Janssen Biotech, INC. | $655.39 | 2019-2024 | Erleada, Akeega |
| Teleflex LLC | $539.09 | 2022-2025 | Barrigel, Urolift |
| Axonics, INC. | $335.28 | 2020-2024 | Bulkamid, Axonics |
| Boston Scientific Corporation | $321.19 | 2019-2023 | Spaceoar Vue System - 10ml, Tria Firm |
| Procept Biorobotics Corporation | $209.55 | 2022-2025 | Aquabeam System |
| Medtronic USA, INC. | $186.71 | 2019 | |
| Valencia Technologies Corporation | $181.56 | 2024 | Ecoin Device Kit |
| Abbvie INC. | $135.12 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $119.76 | 2020-2025 | |
| Myriad Genetic Laboratories, INC. | $118.71 | 2022-2023 | Prolaris |
| Pfizer INC. | $94.32 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $68.50 | 2020-2021 | |
| Angiodynamics, INC. | $62.18 | 2021-2025 | Nanoknife |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $61.94 | 2024-2025 | |
| Palette Life Sciences, INC. | $59.54 | 2022 | |
| Urogen Pharma, INC. | $56.32 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $52.27 | 2023-2024 | Gemtesa |
| Endo Pharmaceuticals INC. | $44.70 | 2023 | Xiaflex, Aveed |
| Immunitybio, INC. | $38.33 | 2025 | |
| Myovant Sciences INC. | $35.28 | 2021 | |
| Halozyme INC | $34.58 | 2023 | |
| Acerus Pharmaceuticals Corporation | $23.50 | 2021 | |
| Metuchen Pharmaceuticals | $21.15 | 2019 | |
| Medtronic, INC. | $19.38 | 2023 | Interstim |
| Cycle Pharmaceuticals INC | $19.10 | 2025 | Venxxiva |
| Calyxo, INC. | $16.55 | 2025 | Cvac Aspiration System |
| Smith+Nephew, INC. | $16.07 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.76 | 2024 | Adstiladrin |
| Therapeuticsmd, INC. | $14.30 | 2019 | |
| Coloplast Corp | $14.28 | 2020 | |
| Ambu INC. | $13.98 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Alver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.